COMMUNIQUÉS West-GlobeNewswire

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
03/04/2024
WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN ), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and [...]
“Cutest Pets on Parliament Hill” Photo Contest: Politics and Pets Collide
03/04/2024
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- In a celebration of the importance of furry companionship amidst the hustle and bustle of Canadian politics, the Canadian Animal Health Institute is thrilled to announce the [...]
Concours photo « Les animaux de compagnie les plus mignons sur la Colline du Parlement » – Le monde politique et nos animaux de compagnie : Le grand débat
03/04/2024
TORONTO, 03 avr. 2024 (GLOBE NEWSWIRE) -- Pour souligner l’importance de la compagnie des animaux à fourrure dans l’effervescence de la politique canadienne, l’Institut canadien de la santé animale est ravi d’annoncer [...]
CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
03/04/2024
- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is the third milestone achieved in the collaboration to date - - CytomX-retains US co-commercialization and [...]
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
03/04/2024
PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: “LIPO”) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant [...]
Healthcare Triangle Breaks New Ground in AI-Powered Patient Data Management with readabl.ai
03/04/2024
PLEASANTON, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), In a pioneering move, a leading health system has partnered with [...]
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics
03/04/2024
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to classical cytogenetic [...]
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/04/2024
FLORHAM PARK, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, [...]
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
03/04/2024
Company’s IP Protection for VAZKEPA® in Europe Now Extended Into 2039 DUBLIN, Ireland and BRIDGEWATER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company [...]
American Oncology Network Expands to Hawaii, Welcomes New Practice to Network
03/04/2024
Hawaii Cancer Care partners with American Oncology Network to continue delivering quality cancer care to the community. HONOLULU, April 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: AONC), one of [...]
CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
03/04/2024
ZUG, Switzerland and BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]
Dr. Marra Francis Joins Genece Health as Chief Medical Officer
03/04/2024
DEL MAR, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Genece Health, a molecular testing company focused on improving cancer detection for lung, breast, ovarian and other cancers, today announced that Marra Francis, MD, [...]
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year
03/04/2024
MISSISSAUGA, Ontario, April 03, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX ® is the #1 recommended iron supplement brand in Canada, based on a national [...]
FeraMAX® est la marque de supplément de fer que les pharmaciens et les médecins au Canada recommandent le plus souvent depuis neuf années consécutives
03/04/2024
Mississauga (Ontario), 03 avr. 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », titre à la Bourse de croissance TSX : RX) est fière d’annoncer que FeraMAX MD est la marque de supplément de fer la plus recommandée [...]
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
03/04/2024
iCAD implements ProFound AI Detection to improve mammography reading and breast cancer detection in low-resource institutions and medically underserved communities NASHUA, N.H., April 03, 2024 (GLOBE NEWSWIRE) -- iCAD, [...]
Apnimed to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/04/2024
CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and [...]
Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
03/04/2024
MONTREAL and CHARLOTTE, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will deliver a company presentation at the 23rd Annual [...]
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/04/2024
THE WOODLANDS, Texas, April 03, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced Jeff Wade, Lexicon’s president and chief financial officer, Tom Garner, Lexicon’s senior vice [...]
Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™
03/04/2024
-- Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) -- -- Over 28,000 cases of multiple sclerosis (MS) are reported to the VA annually -- NEWTOWN, Pa., April [...]

Pages